Meet our team at the CAR-TCR Summit: August 29-Sept. 1, 2023 in Boston, MA.
The CAR-TCR Summit will take place August 29 – September 1 2023 at the Hynes Convention Center in Boston, MA, USA.
Meet our team during the event:
Stop by our booth #H87 to meet our team during the CAR-TCR Summit and learn more about our extended services to bring your cell and gene therapies to life… From process development up to commercial launch, Yposkesi is the full-service CDMO of choice, working by your side, to meet your timelines and budget.
On August 31st our expert Cédrick Rousseaux, Deputy Director of Innovation, Analytical and Process Development will make a speaking presentation at the conference:
Title: “Accelerating Time-to-Clinic for Cell Therapies with a Large-scale Lentivirus Manufacturing Platform”
- Optimized unit operations deliver high yields
- Robust and scalable for clinical and commercial gene-modified cell therapies
- End-to-end from manufacturing to analytics
Date: Thursday, August 31st 2023
Time: 12h30 EDT
Learn more about our newly launched Lentiviral Vector Manufacturing Platform: LentiSure™!
At the beginning of April 2023, Yposkesi launched its new Lentiviral Vector Manufacturing Platform, LentiSure.
LentiSure is providing the premium quality grade lentiviral vectors you need to assure your clinical development and commercial cell and gene therapy pipeline. LentiSure’s robust, scalable, and plug & play-optimized processes enable you to accelerate the time to market of your cell and gene therapies and facilitate better patient outcomes. You obtain a safe and effective product through LentiSure’s high productivity and established analytical methods. LentiSure is the choice for high titers, transduction efficiency, reliability, and accessing scalable production processes with optimized purification techniques.